Select the option that best describes what you are looking for
Boost oncology drug discovery with XenoBase®, featuring the largest cell line selection and exclusive 3D organoid models. Benefit from OrganoidXplore™ and OmniScreen™ for rapid, in-depth analysis.
Enhance drug development with our validated in vivo models, in vitro/ex vivo assays, and in silico modeling. Tailored solutions to optimize your candidates.
Experience ISO-certified biobanking quality. Access top biospecimens from a global clinical network, annotated by experts for precise research.
Leverage our global labs and 150+ scientists for fast, tailored project execution. Benefit from our expertise, cutting-edge tech, and validated workflows for reliable data outcomes.
Harness your data and discover biomarkers with our top bioinformatics expertise. Maximize data value and gain critical insights to accelerate drug discovery and elevate projects.
Accelerate innovative cancer treatments with our advanced models and precise drug screening for KRAS mutations, efficiently turning insights into clinical breakthroughs.
Advance translational pharmacology with our diverse pre-clinical models, robust assays, and data science-driven biomarker analysis, multi-omics, and spatial biology.
Our suite integrates preclinical solutions, bioanalytical read-outs, and multi-omics to uncover drug resistance markers and expedite discovery with our unique four-step strategy.
Enhance treatments with our human tumor and mouse models, including xenografts and organoids, for accurate cancer biology representation.
Journey through the drug discovery pipeline from target discovery to in vivo pharmacology. Take advantage of the Largest biobank of patient-derived models, Model development capabilities, Cell-based assays for Screening ADCs, and advanced downstream analysis.
Leverage comprehensive in vitro, in vivo, ex vivo, and in silico platforms, utilizing immunocompetent, humanized, or patient-derived models. With robust biomarker analysis and a focus on checkpoint inhibitors, you can optimize combination strategies.
Apply the most appropriate in silico framework to your pharmacology data or historical datasets to elevate your study design and analysis, and to improve your chances of clinical success.
Integrate advanced statistics into your drug development projects to gain significant biological insight into your therapeutic candidate, with our expert team of bioinformaticians.
Accelerate your discoveries with our reliable CRISPR solutions. Our global CRISPR licenses cover an integrated drug discovery platform for in vitro and in vivo efficacy studies.
Rely on our experienced genomics services to deliver high quality, interpretable results using highly sensitive PCR-based, real-time PCR, and NGS technologies and advanced data analytics.
Gain more insights into tumor growth and disease progression by leveraging our 2D and 3D fluorescence optical imaging.
Next-generation ion mobility mass spectrometry (MS)-based proteomics services available globally to help meet your study needs.
Gain better insight into the phenotypic response of your therapeutic candidate in organoids and ex vivo patient tissue.
Certified CRO services with NanoString GeoMx Digital Spatial Profiling.
De-risk your drug development with early identification of candidate biomarkers and utilize our biomarker discovery services to optimize clinical trial design.
Rapidly evaluate your molecule’s pharmaceutical and safety properties with our in vivo drug metabolism and pharmacokinetic (DMPK) services to select the most robust drug formulations.
Explore how the novel HuGEMM™ and HuCELL™ platforms can assess the efficacy of your molecule and accelerate your immuno-oncology drug discovery programs.
Employ cutting-edge multi-omics methods to obtain accurate and comprehensive data for optimal data-based decisions.
Leverage our suite of structural biology services including, recombinant protein expression and protein crystallography, and target validation services including RNAi.
Find the most appropriate screen to accelerate your drug development: discover in vivo screens with MuScreen™ and in vitro cell line screening with OmniScreen™.
Carry out safety pharmacology studies as standalone assessments or embedded within our overall toxicological profiling to assess cardiovascular, metabolic and renal/urinary systems.
Learn more about how our consulting services can help to support your journey to the clinic.
Global CRO in California, USA offering preclinical and translational oncology platforms with high-quality in vivo, in vitro, and ex vivo models.
Learn more about the impact we make through our scientific talent, high-quality standards, and innovation.
We build a sustainable future by supporting employee growth, fostering leadership, and exceeding customer needs. Our values focus on innovation, social responsibility, and community well-being.
We build a sustainable future by fostering leadership, employee growth, and exceeding customer needs with innovation and social responsibility.
Our Scientific Advisory Board of experts shapes our strategy and ensures top scientific standards in research and development.
Stay updated with Crown Bioscience's latest news, achievements, and announcements. Check our schedule for upcoming events and plan your visit.
Join us for a fast-paced career addressing life science needs with innovative technologies. Thrive in a respectful, growth-focused environment.
Access our latest scientific research and peer-reviewed articles. Discover cutting-edge findings and insights driving innovation and excellence in bioscience.
Discover valuable insights and curated materials to support your R&D efforts. Explore the latest trends, innovations, and expertly curated content in bioscience.
Explore our blogs for the latest insights, research breakthroughs, and industry trends. Stay educated with expert perspectives and in-depth articles driving innovation in bioscience.
Microbiome study is vital for drug discovery as the microbiome significantly influences drug metabolism, efficacy, and safety. Understanding these interactions can optimize drug dosages, enhance treatment effectiveness, and enable personalized medicine based on an individual's unique microbiome profile. Moreover, the microbiome's impact on drug-induced toxicity and interactions between medications can be identified, leading to safer drug development. Microbiome-targeted therapies offer promising approaches, directly treating conditions or improving drug effects. Microbiome analysis also helps identify biomarkers for diseases and treatment response, advancing diagnostic tools and precision medicine. Integrating microbiome data into drug development can revolutionize healthcare by improving treatment outcome
Microbiome sequencing provids insights into complex microbial communities. Choose our microbiome sequencing services for:
Crown Bioscience leads in comprehensive and cost-effective full-length 16S rRNA analysis using PacBio's long-read third-generation sequencing. Our approach offers distinct advantages over short read sequencing. By capturing the entire 16S rRNA gene, we provide unparalleled insights into bacterial diversity and ensure precise taxonomic classification. Overcoming limitations of short read methods, such as primer bias and reduced taxonomic resolution, our full-length sequencing delivers a comprehensive and unbiased view of the microbial community. This empowers the identification of potential drug targets and deepens understanding of their functional roles.
Traditional 16S Sequencing |
Full-Length 16S Sequencing |
|
Sequencing Platform |
Short Read Sequencing |
Long Read Sequencing |
Targeted Region |
Short hypervariable region |
Entire 16S rRNA gene |
Taxonomic Resolution |
Moderate |
Higher |
Primer Bias |
Yes |
Reduced |
Secondary Structure |
Not captured |
Captured |
Fig. Commonly used DNA regions in short-read and long-read 16S rRNA sequencing
Metagenomic sequencing provides a significant advantage over 16S rRNA sequencing by capturing comprehensive genomic information. This empowers higher taxonomic resolution, direct functional profiling, and the identification of novel or rare species. While it comes at a higher cost and requires specialized bioinformatics expertise, shotgun sequencing is an ideal choice for researchers looking to delve into a smaller number of samples with greater depth compared to amplicon sequencing. Embrace the power of metagenomic sequencing to unlock a wealth of valuable insights about microbial communities and their functional potential.
Metatranscriptomic sequencing studies the gene expression profiles of microbial communities, providing insights into their functional activities and responses to the environment. By analyzing RNA molecules, researchers can identify actively expressed genes, revealing the metabolic pathways and biological processes within the microbiome. This approach enhances our understanding of how microbes interact with their surroundings and contribute to ecosystem functions and host-associated processes.
Methods |
Applications |
Advantages |
Limitations |
Full-length 16S rRNA |
|
|
|
Shotgun Metagenomic |
|
|
|
Metatranscriptomic |
|
|
|
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2023-11-29
2023-10-20
site_page
Genomics